Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $130.00 by Analysts at Citigroup
Merck & Co., Inc. (NYSE:MRK – Free Report) had its target price lowered by Citigroup from $140.00 to $130.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a buy rating on the stock. MRK has been the topic of a number of other research reports. Evercore ISI raised […]
26 Oct 13:32 · The Cerbat Gem